ARGENX SE SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KARGENX SEARGXOct 8

   ARGENX SE reports positive Phase 2 results for FB102

   • Phase 2 study met primary endpoint (p=0.0176)
   • FB102 showed significant treatment effect vs. placebo
   • No new safety signals identified
2. ROUTINE6-KARGENX SEARGXSep 29

   Foreign issuer report

3. ROUTINE6-KARGENX SEARGXAug 27

   Foreign issuer report

4. ROUTINESC TO-T/AForte Biosciences, Inc.FBRXAug 27

   Tender offer (amended)

   Se Argenx, filed by

5. ROUTINESC TO-T/AForte Biosciences, Inc.FBRXAug 20

   Tender offer (amended)

   Se Argenx, filed by

6. ROUTINE6-KARGENX SEARGXAug 17

   Foreign issuer report

7. ROUTINESCHEDULE 13G/AARGENX SEARGXAug 14

   Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/ (amended)

   PRICE T ROWE ASSOCIATES INC /MD/, filed by

8. ROUTINESC TO-T/AForte Biosciences, Inc.FBRXAug 6

   Tender offer (amended)

   Se Argenx, filed by

9. NOTABLESC TO-TForte Biosciences, Inc.FBRXAug 6

   Tender offer

   Se Argenx, filed by

10. ROUTINE6-KARGENX SEARGXAug 3

    Foreign issuer report

11. ROUTINESC TO-CForte Biosciences, Inc.FBRXJul 28

    SC TO-C filing

    Se Argenx, filed by

12. ROUTINESC TO-CForte Biosciences, Inc.FBRXJul 27

    SC TO-C filing

    Se Argenx, filed by

13. ROUTINE6-KARGENX SEARGXJul 27

    Foreign issuer report

14. ROUTINE6-KARGENX SEARGXJul 23

    Foreign issuer report

15. ROUTINE6-KARGENX SEARGXJun 23

    Foreign issuer report

16. ROUTINE6-KARGENX SEARGXJun 3

    Foreign issuer report

17. ROUTINE6-KARGENX SEARGXMay 7

    Foreign issuer report

18. ROUTINE6-KARGENX SEARGXMay 6

    Foreign issuer report

19. ROUTINESCHEDULE 13G/AARGENX SEARGXMay 6

    Ownership stake disclosure by FMR LLC (amended)

    FMR LLC, filed by

20. ROUTINE6-KARGENX SEARGXApr 20

    Foreign issuer report

21. ROUTINE6-KARGENX SEARGXMar 20

    Foreign issuer report

22. NOTABLE20-FARGENX SEARGXMar 19

    Annual report

23. ROUTINE6-KARGENX SEARGXMar 19

    Foreign issuer report

24. ROUTINE6-KARGENX SEARGXMar 6

    Foreign issuer report

25. ROUTINE6-KARGENX SEARGXFeb 26

    Foreign issuer report

26. ROUTINE6-KARGENX SEARGXFeb 26

    Foreign issuer report

27. ROUTINE6-KARGENX SEARGXJan 13

    Foreign issuer report

28. ROUTINE6-KARGENX SEARGXJan 12

    Foreign issuer report

29. ROUTINE6-KARGENX SEARGXJan 5

    Foreign issuer report

30. ROUTINES-8ARGENX SEARGXDec 17, 2025

    Employee stock plan registration

31. ROUTINE6-KARGENX SEARGXDec 15, 2025

    Foreign issuer report

32. ROUTINE6-KARGENX SEARGXNov 19, 2025

    ARGENX SE filed 6-K

    • Form Type: 6-K
    • Filing Date: 2025-11-18
33. ROUTINESCHEDULE 13G/AARGENX SEARGXNov 14, 2025

    Ownership stake disclosure by PRICE T ROWE ASSOCIATES INC /MD/ (amended)

    PRICE T ROWE ASSOCIATES INC /MD/, filed by

Older filings on EDGAR